Yang, C Y <br/><br/>
Effects of gemfibrozil on very-low-density lipoprotein composition and low-density lipoprotein size in patients with hypertriglyceridemia or combined hyperlipidemia.  [electronic resource] 

 -  Atherosclerosis  Sep 1996 
 - 105-16 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-9150 
<br/><br/><label>Standard No.: </label>10.1016/0021-9150(96)05899-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Apolipoproteins E--blood<br/>Cross-Over Studies<br/>Enzyme-Linked Immunosorbent Assay<br/>Gemfibrozil--pharmacology<br/>Humans<br/>Hyperlipidemias--blood<br/>Hypertriglyceridemia--blood<br/>Hypolipidemic Agents--pharmacology<br/>Lipoproteins, LDL--blood<br/>Lipoproteins, VLDL--blood<br/>Male<br/>Middle Aged<br/>Molecular Weight